We are pleased to announce that Cygames Inc. has generously made a significant donation to support the AIM research at IAM, particularly the development of medicine for cat kidney diseases. Since last summer, we have received voluntary donations from tens of thousands of individuals who resonate with AIM research. Additionally, we are humbled and deeply grateful to receive this substantial donation from Cygames, a company from a different field that recognizes the importance of our research. This reaffirms the wide societal expectation for our work and further strengthens our commitment to AIM drug development.

We would like to extend our heartfelt gratitude to Cygames Inc. for their generous contribution. With your support, we are even more motivated to dedicate ourselves to our research efforts. We assure you that we will strive to meet your expectations. We sincerely ask for your continued support and encouragement for IAM.

Sincerely,
Director and President of IAM, Toru Miyazaki